Literature DB >> 36136272

The pro-tumorigenic responses in metastatic niches: an immunological perspective.

Mohammad Hossein Mirzapour1,2, Mahsa Heidari-Foroozan2,3, Sepideh Razi2,4,5, Nima Rezaei6,7,8.   

Abstract

Metastasis is the leading cause of mortality related to cancer. In the course of metastasis, cancer cells detach from the primary tumor, enter the circulation, extravasate at secondary sites, and colonize there. All of these steps are rate limiting and decrease the efficiency of metastasis. Prior to their arrival, tumor cells can modify the secondary sites. These favorable microenvironments increase the probability of successful dissemination and are referred to as pre-metastatic niches. Cancer cells use different mechanisms to induce and maintain these niches, among which immune cells play prominent roles. The immune system, including innate and adaptive, enhances recruitment, extravasation, and colonization of tumor cells at distant sites. In addition to immune cells, stromal cells can also contribute to forming pre-metastatic niches. This review summarizes the pro-metastatic responses conducted by immune cells and the assistance of stromal cells and endothelial cells in the induction of pre-metastatic niches.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Cancer immunology; Immune cells; Metastasis; Pre-metastatic niches; Stromal cells; Tumorigenesis

Year:  2022        PMID: 36136272     DOI: 10.1007/s12094-022-02950-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  16 in total

1.  Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs.

Authors:  Qing Chen; Xiang H-F Zhang; Joan Massagué
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

2.  Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells.

Authors:  Johannes Clausen; Birgit Vergeiner; Martina Enk; Andreas L Petzer; Günther Gastl; Eberhard Gunsilius
Journal:  Immunobiology       Date:  2003       Impact factor: 3.144

3.  Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils.

Authors:  Amy-Jo Casbon; Damien Reynaud; Chanhyuk Park; Emily Khuc; Dennis D Gan; Koen Schepers; Emmanuelle Passegué; Zena Werb
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

4.  Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes.

Authors:  Marcin Kowanetz; Xiumin Wu; John Lee; Martha Tan; Thijs Hagenbeek; Xueping Qu; Lanlan Yu; Jed Ross; Nina Korsisaari; Tim Cao; Hani Bou-Reslan; Dara Kallop; Robby Weimer; Mary J C Ludlam; Joshua S Kaminker; Zora Modrusan; Nicholas van Bruggen; Franklin V Peale; Richard Carano; Y Gloria Meng; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-16       Impact factor: 11.205

5.  Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung.

Authors:  Hannah H Yan; Michael Pickup; Yanli Pang; Agnieszka E Gorska; Zhaoyang Li; Anna Chytil; Yipeng Geng; Jerome W Gray; Harold L Moses; Li Yang
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

6.  Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth.

Authors:  Kshitij Srivastava; Junhao Hu; Claudia Korn; Soniya Savant; Martin Teichert; Stephanie S Kapel; Manfred Jugold; Eva Besemfelder; Markus Thomas; Manolis Pasparakis; Hellmut G Augustin
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

7.  The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.

Authors:  Sachie Hiratsuka; Akira Watanabe; Yoshiko Sakurai; Sachiko Akashi-Takamura; Sachie Ishibashi; Kensuke Miyake; Masabumi Shibuya; Shizuo Akira; Hiroyuki Aburatani; Yoshiro Maru
Journal:  Nat Cell Biol       Date:  2008-09-28       Impact factor: 28.824

Review 8.  Neutrophils as effector cells for antibody-based immunotherapy of cancer.

Authors:  Marjolein van Egmond; Jantine E Bakema
Journal:  Semin Cancer Biol       Date:  2012-12-31       Impact factor: 15.707

Review 9.  The metastatic niche: adapting the foreign soil.

Authors:  Bethan Psaila; David Lyden
Journal:  Nat Rev Cancer       Date:  2009-04       Impact factor: 60.716

10.  MET is required for the recruitment of anti-tumoural neutrophils.

Authors:  Veronica Finisguerra; Giusy Di Conza; Mario Di Matteo; Jens Serneels; Sandra Costa; A A Roger Thompson; Els Wauters; Sarah Walmsley; Hans Prenen; Zvi Granot; Andrea Casazza; Massimiliano Mazzone
Journal:  Nature       Date:  2015-05-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.